Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lüftner

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
The International Journal of Biological Markers|November 1, 2002
Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in the serum of healthy adultsK Jung, M Lein, K v Hösslin, et al.
Anticancer Research|May 1, 2001
Tumor type M2 pyruvate kinase expression in advanced breast cancerD Lüftner, J Mesterharm, C Akrivakis, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2001
CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 casesM Gion, R Mione, A E Leon, et al.
Anticancer Research|July 22, 2005
PINP as serum marker of metastatic spread to the bone in breast cancer patientsD Lüftner, D Jozereau, S Schildhauer, et al.
Anticancer Research|June 25, 2003
Plasma levels of HER-2/neu, tumor type M2 pyruvate kinase and its tyrosine-phosphorylated metabolite in advanced breast cancerD Lüftner, S Mazurek, P Henschke, et al.
Anticancer Research|September 2, 1999
The course of the urinary DPD-crosslink secretion in metastatic breast cancer--a possibility for response assessmentD Lüftner, S Günther, B Flath, et al.
Anticancer Research|January 12, 2000
Adjuvant high-dose chemotherapy with epirubicin and ifosfamide in nodal positive breast cancerD Lüftner, K Wagner, G Dingeldein, et al.
Annals of Hematology|December 29, 2000
Patients with malignant lymphomas experience a higher rate of documented infections than patients with breast cancer after high-dose chemotherapy with autologous peripheral stem cell transplantationO Sezer, J Eucker, C Bauhuis, et al.
Physical Chemistry Chemical Physics : PCCP|December 6, 2014
The interplay between interface structure, energy level alignment and chemical bonding strength at organic-metal interfacesM Willenbockel, D Lüftner, B Stadtmüller, et al.
Geburtshilfe Und Frauenheilkunde|October 18, 2014
Breast Cancer 2012 - New AspectsH-C Kolberg, D Lüftner, M P Lux, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
The International Journal of Biological Markers|November 1, 2002
Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in the serum of healthy adultsK Jung, M Lein, K v Hösslin, et al.
Anticancer Research|May 1, 2001
Tumor type M2 pyruvate kinase expression in advanced breast cancerD Lüftner, J Mesterharm, C Akrivakis, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2001
CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 casesM Gion, R Mione, A E Leon, et al.
Anticancer Research|July 22, 2005
PINP as serum marker of metastatic spread to the bone in breast cancer patientsD Lüftner, D Jozereau, S Schildhauer, et al.
Anticancer Research|June 25, 2003
Plasma levels of HER-2/neu, tumor type M2 pyruvate kinase and its tyrosine-phosphorylated metabolite in advanced breast cancerD Lüftner, S Mazurek, P Henschke, et al.
Anticancer Research|September 2, 1999
The course of the urinary DPD-crosslink secretion in metastatic breast cancer--a possibility for response assessmentD Lüftner, S Günther, B Flath, et al.
Anticancer Research|January 12, 2000
Adjuvant high-dose chemotherapy with epirubicin and ifosfamide in nodal positive breast cancerD Lüftner, K Wagner, G Dingeldein, et al.
Annals of Hematology|December 29, 2000
Patients with malignant lymphomas experience a higher rate of documented infections than patients with breast cancer after high-dose chemotherapy with autologous peripheral stem cell transplantationO Sezer, J Eucker, C Bauhuis, et al.
Physical Chemistry Chemical Physics : PCCP|December 6, 2014
The interplay between interface structure, energy level alignment and chemical bonding strength at organic-metal interfacesM Willenbockel, D Lüftner, B Stadtmüller, et al.
Geburtshilfe Und Frauenheilkunde|October 18, 2014
Breast Cancer 2012 - New AspectsH-C Kolberg, D Lüftner, M P Lux, et al.
Pageof 5